An injectable, nanostructured implant for the delivery of adenosine triphosphate: towards long-acting formulations of small, hydrophilic drugs
Drug Delivery and Translational Research · 2024
DOI: 10.1007/s13346-024-01631-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2024. Verfasst von Giovanna Giacalone und 8 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, Orsay, 91400, France. Hauptthemen laut MEDLINE: Adenosine Triphosphate, Hydrophobic and Hydrophilic Interactions, Chitosan, Nanostructures. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Université Paris-Saclay, Agence Nationale de la Recherche.
Abstract (Originalsprache)
While long-acting injectable treatments are gaining increasing interest in managing chronic diseases, the available drug delivery systems almost exclusively rely on hydrophobic matrixes, limiting their application to either hydrophobic drugs or large and hydrophilic molecules such as peptides. To address the technological lock for long-acting delivery systems tailored to small, hydrophilic drugs such as anticancer and antiviral nucleoside/nucleotide analogues, we have synthesized and characterized an original approach with a multi-scale structure: (i) a nucleotide (adenosine triphosphate, ATP) is first incorporated in hydrophilic chitosan-Fe(III) nanogels; (ii) these nanogels are then transferred by freeze-drying and resuspension into a water-free, hydrophobic medium containing PLGA and an organic solvent, N-methyl-2-pyrrolidone. We show that this specific association allows an injectable and homogeneous dispersion, able to form in situ implants upon injection in physiological or aqueous environments. This system releases ATP in vitro without any burst effect in a two-step mechanism, first as nanogels acting as an intermediate reservoir over a week, then as free drug over several weeks. In vivo studies confirmed the potential of such nanostructured implants for sustained drug release following subcutaneous injection to mice hock, opening perspectives for sustained and targeted delivery through the lymphatic system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, Orsay, 91400, France.
- Université Paris-Saclay, MIPSIT Microscopy Facility, IPSIT, Orsay, 91400, France.
- Light Microscopy Facility Imagerie-Gif, CNRS - I2BC (present address), Gif-sur-Yvette, 91198, France.
- Electron Microscopy Facility, Imagerie-Gif, Institute for Integrative Biology of the Cell (I2BC), Université Paris-Saclay, CEA, CNRS, Gif-sur-Yvette, 91198, France.
- Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, Orsay, 91400, France. herve.hillaireau@universite-paris-saclay.fr.
ORCID-Profile: Hervé Hillaireau
Förderung
- Université Paris-Saclay
- Agence Nationale de la Recherche
Zitieren
APA
Giacalone, G., Quaillet, M., Huang, N., Nicolas, V., Boulogne, C., Gillet, C., Fattal, E., Bochot, A., & Hillaireau, H. (2024). An injectable, nanostructured implant for the delivery of adenosine triphosphate: towards long-acting formulations of small, hydrophilic drugs. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01631-9
Vancouver
Giacalone G, Quaillet M, Huang N, Nicolas V, Boulogne C, Gillet C, et al. An injectable, nanostructured implant for the delivery of adenosine triphosphate: towards long-acting formulations of small, hydrophilic drugs. Drug Delivery and Translational Research. 2024. doi:10.1007/s13346-024-01631-9
BibTeX
@article{Giacalone2024,
author = {Giacalone, Giovanna and Quaillet, Marion and Huang, Nicolas and Nicolas, Valérie and Boulogne, Claire and Gillet, Cynthia and Fattal, Elias and Bochot, Amélie and Hillaireau, Hervé},
title = {An injectable, nanostructured implant for the delivery of adenosine triphosphate: towards long-acting formulations of small, hydrophilic drugs},
journal = {Drug Delivery and Translational Research},
year = {2024},
doi = {10.1007/s13346-024-01631-9}
}
EUVIMED